Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Does the introduction of combination chemotherapy and targeted agents improve overall survival in pancreatic adenocarcinoma?
Invited Paper
